Moderna's mRNA flu vaccine, mFlusiva, offers option for adults 50-64 with potential benefits over traditional shot

https://abc7ny.com/amp/post/modernas-mrna-flu-vaccine-mflusiva-offers-option-adults-50-64-potential-benefits-traditional-shot/19790746/